|Bid||71.73 x 1100|
|Ask||72.04 x 1800|
|Day's Range||70.60 - 72.60|
|52 Week Range||17.01 - 114.55|
|Beta (5Y Monthly)||0.46|
|PE Ratio (TTM)||56.13|
|Earnings Date||Nov 02, 2021 - Nov 08, 2021|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||91.00|
Subscribe to Yahoo Finance Plus to view Fair Value for AMEHLearn more
AMN vs. AMEH: Which Stock Is the Better Value Option?
It's only natural that many investors, especially those who are new to the game, prefer to buy shares in 'sexy' stocks...
Clinigence Holdings, Inc. ("Clinigence") (OTC: CLNH), one of the nation's leading technology-enabled, risk-bearing population health management companies, today announced that it has completed a $3 million strategic equity investment from Apollo Medical Holdings, Inc. ("ApolloMed") (NASDAQ: AMEH), one of the largest physician-centric, technology-powered, risk-bearing healthcare companies in the country.